Explore more publications!

Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

Press releases published on March 5, 2026

NextCure Provides Business Update and Reports Full Year 2025 Financial Results
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Omada Health Reports Fourth Quarter and Full-Year 2025 Results
Galapagos Appoints Tania Philipp as Chief Human Resources Officer
Galapagos benoemt Tania Philipp tot Chief Human Resources Officer
aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
ArriVent BioPharma Reports Full Year 2025 Financial Results
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
Ballad Health opens newest NICU in Tennessee and Virginia at Niswonger Children’s Hospital
Truveta joins leading experts in calling for public utility framework to govern real-world health data
Buck Institute Launches Healthspan Horizons to Make Long-Term Health Measurable and Actionable
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions
Quanta Therapeutics Presents Preclinical Data Establishing that Direct Multi-KRAS Inhibitors Retain Strong Activity Against Resistance Mechanisms Acquired from Treatment with pan-RAS Tri-Complex Inhibitors
Hopewell Therapeutics Announces Sublicense of Proprietary Lipid Nanoparticles for Novel Cancer Vaccine to Foxcroft Therapeutics
Atlantic Health, Lawrence Cooper to Be Honored at Partnership for a Drug-Free New Jersey’s  Angel of Hope Gala

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions